Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

In an effort to better serve our users, we have streamlined our content offering. As a result, we no longer publish new content or update existing content in Brain Cancer. Visit the 'Content & Subscriptions' tab of your Settings page at any time to update your Dashboard or Newsletter Subscription preferences to continue to see news and information that interests you most.

featured
Published in Brain Cancer

Expert Opinion / Cases · April 01, 2022

Treatment of Leptomeningeal Metastases From Triple-Negative Breast Cancer

Written by
L. Nicolas Gonzalez Castro MD, PhD

 

Additional Info

Disclosure statements are available on the authors' profiles:

Discuss This item Follow

No comments yet, be the first to start the discussion!

  • Amir Anvari

    Apr 01, 2022

    My recommendation  FRIST WBRT  30 GY IN 10 FRACTION  then intrathecal chemotherapy with mtx +cytarabine  

  • Anastasiia Nechaeva

    Apr 09, 2022

    Whether ventriculoperitoneal shunt increases risks of malignant cells dissemination?

  • Andre Dreyer

    Jul 24, 2023

    I would do craniospinal RT using VMAT followed by chemo- capecitabine and temozolomide

  • Apr 21, 2024

    Pending Moderator approval.
    Delete

Further Reading